Truist Reiterates Buy Rating for Viridian Therapeutics (VRDN)

On April 21, Truist reduced the terms people connected Viridian Therapeutics Inc. (NASDAQ:VRDN) from $36 to $33 portion maintaining a Buy standing connected the stock. Despite the downward revision successful people price, the banal inactive offers an charismatic upside imaginable of much than 140%, making it 1 of the champion oversold small-cap names.

Likoper/Shutterstock.com

The steadfast is modifying its exemplary based connected revised assumptions astir measurement and pricing, keeping successful caput a imaginable motorboat of Veli for some acute and chronic thyroid oculus disease. It continues to clasp affirmative sentiment towards the banal owed to the disposable catalysts ahead.

On April 8, Laura Chico from Wedbush maintained an Outperform standing for Viridian Therapeutics Inc. (NASDAQ:VRDN) portion reducing the people terms from $37 to $31. The expert noted that implicit the past respective years, the institution has efficaciously managed a fig of competitory threats successful the industry.

However, Chico cautions that, successful airy of a caller pipeline update from Amgen connected its Tepezza on-body injector, cautious marketplace reflection is necessary. Using this antithetic medication method, Amgen Inc. (NASDAQ:AMGN) reported a beardown 57% placebo-adjusted proptosis response. Laura believes that the impending merchandise of affirmative REVEAL-2 objective results volition proceed to beryllium the large catalyst for elegrobart’s value. For the 2nd 4th of 2026, this important pipeline milestone is inactive good connected schedule.

Viridian Therapeutics Inc. (NASDAQ:VRDN) is progressive successful discovering and selling treatments for uncommon and superior illnesses. It produces 3 main therapeutics, which see Veligrotrug, Elegrobart, and anti-thyroid-stimulating hormone receptor (TSHR). Its portfolio of engineered inhibitors of the neonatal Fc receptor (FcFn) includes VRDN-008 and VRDN-006.

While we admit the imaginable of VRDN arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and 15 Stocks That Will Make You Rich successful 10 Years.

Disclosure: None. Follow Insider Monkey connected Google News.